Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study

Stopped early · Not applicable · Has a placebo group

Conditions studied: Ileostomy - Stoma

In brief

Consenting subjects will be randomized to receive injection of bupivacaine or placebo before surgery for ileostomy takedown (injection administered after general anesthesia has been administered). Pain and side effects will be assessed periodically after surgery using the verbal Numeric Rating pain Scores, including at the timepoint of 24 hours after surgery. All subjects in this study will be given toradol to ensure adequate pain control.

Key facts

Study ID

NCT01411917

Run by

University of Wisconsin, Madison

People needed

69

Starts

2011-08-01

Expected to finish

2015-11-30

Last updated by the study team

2019-06-10

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients having an ileostomy takedown alone, on one side of abdomen
• Ages 18-80 inclusive
• English speaking
• BMI less than 40
• Ability to understand verbal pain scale
• American Society of Anesthesiologists (ASA) Physical Status 1-3

You may not qualify if…

• Allergy to local anesthetics
• History of recent/current local or generalized infection
• Immunocompromised
• Significant psychiatric disease
• History of opioid dependence
• Pregnancy or lactation
• A prisoner.
• Significant liver disease
• Contraindication to ondansetron or dexamethasone
• Clinically significant cardiac or pulmonary disease

Where it is running

• University of Wisconsin School of Medicine and Public Health — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.